Handelsbanken Fonder
LEGN icon

Handelsbanken Fonder’s Legend Biotech LEGN Stock Holding History

Handelsbanken Fonder’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2M Sell
41,500
-500
-1% -$13.5K ﹤0.01% 1049
2026
Q1 		$760K Hold
42,000
– – ﹤0.01% 1161
2025
Q4 		$913K Buy
42,000
+17,100
+69% +$490K ﹤0.01% 1074
2025
Q3 		$812K Hold
24,900
– – ﹤0.01% 1088
2025
Q2 		$884K Sell
24,900
-25,000
-50% -$810K ﹤0.01% 1010
2025
Q1 		$1.69M Sell
49,900
-600
-1% -$21.5K 0.01% 715
2024
Q4 		$1.64M Hold
50,500
– – 0.01% 748
2024
Q3 		$2.46M Buy
50,500
+3,600
+8% +$192K 0.01% 597
2024
Q2 		$2.08M Buy
46,900
+7,200
+18% +$332K 0.01% 581
2024
Q1 		$2.23M Hold
39,700
– – 0.01% 575
2023
Q4 		$2.39M Buy
39,700
+7,700
+24% +$488K 0.01% 520
2023
Q3 		$2.15M Buy
32,000
+4,700
+17% +$326K 0.01% 533
2023
Q2 		$1.89M Buy
27,300
+1,300
+5% +$84.9K 0.01% 554
2023
Q1 		$1.25M Buy
26,000
+4,900
+23% +$240K 0.01% 622
2022
Q4 		$1.05M Buy
+21,100
New +$1.02M 0.01% 643

Other funds holding LEGN

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
AWM
Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
AP
Aspect Partners Fairfax, Virginia $268M AUM 22.57% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Handelsbanken Fonder's LEGN Position: Q2 2026 in Review

Handelsbanken Fonder reduced its Legend Biotech (LEGN) stake by 1.2% in Q2 2026, selling an estimated $13.5K and leaving 41,500 shares worth $1.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1049.

Handelsbanken Fonder first reported a position in LEGN in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.46M in Q3 2024. 14 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Handelsbanken Fonder held 41,500 shares of Legend Biotech worth $1.2M as of Q2 2026.
  • Handelsbanken Fonder sold 500 Legend Biotech shares in Q2 2026, an estimated $13.5K.
  • Legend Biotech made up ﹤0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #1049 holding.
  • Handelsbanken Fonder first reported a position in Legend Biotech in Q4 2022 and has held it in 15 quarters since.
  • Handelsbanken Fonder's Legend Biotech position peaked at $2.46M in Q3 2024.
  • 14 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.